Home › NDC Lookup › RxCUI directory › RxCUI 198471

Aspirin 500 MG Oral Tablet — RxCUI 198471

RxNorm drug concept · Semantic clinical drug
RxCUI 198471 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198471
Official nameAspirin 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asASA 500 MG Oral Tablet
FDA products mapped3
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. A rectal suppository gets the medication into your system through the lining of the rectum rather than your stomach. This can be helpful if you're having trouble sw...
  • Why would someone use a rectal suppository instead of just taking aspirin by mouth?
  • First, check that the foil or plastic packet is fully sealed and undamaged before you open it — don't use it if it looks like it's already been opened. Once you open it, insert the...
  • This is really important: aspirin — including the suppository form — should NOT be given to children or teenagers who have or are recovering from chicken pox or the flu. There is a...
📖 Read our full Aspirin Rectal guide →

🕸️ Concept Web — How Aspirin 500 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aspirin 500 MG Oral Tablet RxCUI 198471

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Aspirin 1191
  2. Brand names 3

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bayer Aspirin 215568
    • Bufferin 215770
    • Norwich Aspirin 218783
  3. Dose forms 15

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aspirin Oral Tablet 370611
    • Aspirin Oral Product 1154069
    • Aspirin Pill 1154070
    • Aspirin Oral Tablet [Bayer Aspirin] 368457
    • Aspirin Oral Tablet [Bufferin] 368653
    • Aspirin Oral Tablet [Norwich Aspirin] 368468
    • Bayer Aspirin Oral Product 1168628
    • Bayer Aspirin Pill 1168631
    • +7 more in this family
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Aspirin 500 MG 315424
    • Aspirin 500 MG Oral Tablet [Bayer Aspirin] 211887
    • Aspirin 500 MG Oral Tablet [Bufferin] 848166
    • Aspirin 500 MG Oral Tablet [Norwich Aspirin] 211891
    • Aspirin 500 MG [Bayer Aspirin] 572216
    • Aspirin 500 MG [Bufferin] 848165
    • Aspirin 500 MG [Norwich Aspirin] 572220

Showing up to 8 concepts per family — 19 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aspirin 500 MG SCDC · 315424
  • Aspirin Oral Tablet SCDF · 370611
  • Aspirin Oral Product SCDG · 1154069
  • Aspirin Pill SCDG · 1154070

Brand-Name Concepts

  • Aspirin 500 MG Oral Tablet [Bayer Aspirin] SBD · 211887
  • Aspirin 500 MG Oral Tablet [Bufferin] SBD · 848166
  • Aspirin 500 MG Oral Tablet [Norwich Aspirin] SBD · 211891
  • Aspirin 500 MG [Bayer Aspirin] SBDC · 572216
  • Aspirin 500 MG [Bufferin] SBDC · 848165
  • Aspirin 500 MG [Norwich Aspirin] SBDC · 572220
  • Aspirin Oral Tablet [Bayer Aspirin] SBDF · 368457
  • Aspirin Oral Tablet [Bufferin] SBDF · 368653
  • Aspirin Oral Tablet [Norwich Aspirin] SBDF · 368468
  • Bayer Aspirin Oral Product SBDG · 1168628

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 198471 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00280-0161-01 1 BOTTLE, PLASTIC in 1 CARTON (0280-0161-01) / 50 TABLET in... Aspirina Caplets Bayer HealthCare LLC. 2025-05-01
00280-2020-10 1 BOTTLE, PLASTIC in 1 CARTON (0280-2020-10) / 100 TABLET i... BAYER Aspirin Extra Strength Caplets Bayer HealthCare LLC. 2014-12-23
49483-0382-00 100000 TABLET, COATED in 1 CARTON (49483-382-00) ASPIRIN EXTRA STRENGTH Time-Cap Labs, Inc 2018-12-17
49483-0382-01 100 TABLET, COATED in 1 BOTTLE, PLASTIC (49483-382-01) ASPIRIN EXTRA STRENGTH Time-Cap Labs, Inc 2018-12-17
Observed labelers: Bayer HealthCare LLC. (2) · Time-Cap Labs, Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.